187 related articles for article (PubMed ID: 26133914)
1. Ursodeoxycholic acid effectively kills drug-resistant gastric cancer cells through induction of autophagic death.
Lim SC; Han SI
Oncol Rep; 2015 Sep; 34(3):1261-8. PubMed ID: 26133914
[TBL] [Abstract][Full Text] [Related]
2. Lipid raft-dependent death receptor 5 (DR5) expression and activation are critical for ursodeoxycholic acid-induced apoptosis in gastric cancer cells.
Lim SC; Duong HQ; Choi JE; Lee TB; Kang JH; Oh SH; Han SI
Carcinogenesis; 2011 May; 32(5):723-31. PubMed ID: 21362627
[TBL] [Abstract][Full Text] [Related]
3. Pro-apoptotic role of the MEK/ERK pathway in ursodeoxycholic acid-induced apoptosis in SNU601 gastric cancer cells.
Lim SC; Duong HQ; Parajuli KR; Han SI
Oncol Rep; 2012 Oct; 28(4):1429-34. PubMed ID: 22824956
[TBL] [Abstract][Full Text] [Related]
4. Cholesterol induces autophagic and apoptotic death in gastric carcinoma cells.
Lim SC; Parajuli KR; Duong HQ; Choi JE; Han SI
Int J Oncol; 2014 Mar; 44(3):805-11. PubMed ID: 24399152
[TBL] [Abstract][Full Text] [Related]
5. The alkyllysophospholipid edelfosine enhances TRAIL-mediated apoptosis in gastric cancer cells through death receptor 5 and the mitochondrial pathway.
Lim SC; Parajuli KR; Han SI
Tumour Biol; 2016 May; 37(5):6205-16. PubMed ID: 26615420
[TBL] [Abstract][Full Text] [Related]
6. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
[TBL] [Abstract][Full Text] [Related]
7. Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Apoptosis; 2011 Oct; 16(10):1042-53. PubMed ID: 21779837
[TBL] [Abstract][Full Text] [Related]
8. Anticancer Effect of Ursodeoxycholic Acid in Human Oral Squamous Carcinoma HSC-3 Cells through the Caspases.
Pang L; Zhao X; Liu W; Deng J; Tan X; Qiu L
Nutrients; 2015 May; 7(5):3200-18. PubMed ID: 25951128
[TBL] [Abstract][Full Text] [Related]
9. Absence of death receptor translocation into lipid rafts in acquired TRAIL-resistant NSCLC cells.
Ouyang W; Yang C; Zhang S; Liu Y; Yang B; Zhang J; Zhou F; Zhou Y; Xie C
Int J Oncol; 2013 Feb; 42(2):699-711. PubMed ID: 23258590
[TBL] [Abstract][Full Text] [Related]
10. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.
Delmas D; Rébé C; Micheau O; Athias A; Gambert P; Grazide S; Laurent G; Latruffe N; Solary E
Oncogene; 2004 Nov; 23(55):8979-86. PubMed ID: 15480430
[TBL] [Abstract][Full Text] [Related]
11. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
[TBL] [Abstract][Full Text] [Related]
12. 2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human gastric cancer cells through downregulating JNK-mediated cytoprotective autophagy.
Xu Y; Wang Q; Zhang L; Zheng M
Cancer Chemother Pharmacol; 2018 Mar; 81(3):555-564. PubMed ID: 29383484
[TBL] [Abstract][Full Text] [Related]
13. [Cisplatin enhances TRAIL-induced apoptosis in gastric cancer cells through clustering death receptor 4 into lipid rafts].
Xu L; Qu XJ; Liu YP; Liu J; Zhang Y; Hou KZ; Jiang YH
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):484-8. PubMed ID: 22093622
[TBL] [Abstract][Full Text] [Related]
14. Keratin 6, induced by chronic cisplatin exposure, confers chemoresistance in human gastric carcinoma cells.
Lim SC; Parajuli KR; Han SI
Oncol Rep; 2019 Aug; 42(2):797-804. PubMed ID: 31233200
[TBL] [Abstract][Full Text] [Related]
15. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
16. Kallikrein-related peptidase 6 induces chemotherapeutic resistance by attenuating auranofin-induced cell death through activation of autophagy in gastric cancer.
Kim TW; Lee SJ; Kim JT; Kim SJ; Min JK; Bae KH; Jung H; Kim BY; Lim JS; Yang Y; Yoon DY; Choe YK; Lee HG
Oncotarget; 2016 Dec; 7(51):85332-85348. PubMed ID: 27863404
[TBL] [Abstract][Full Text] [Related]
17. Involvement of DR4/JNK pathway-mediated autophagy in acquired TRAIL resistance in HepG2 cells.
Lim SC; Jeon HJ; Kee KH; Lee MJ; Hong R; Han SI
Int J Oncol; 2016 Nov; 49(5):1983-1990. PubMed ID: 27665736
[TBL] [Abstract][Full Text] [Related]
18. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
19. Akebia saponin PA induces autophagic and apoptotic cell death in AGS human gastric cancer cells.
Xu MY; Lee DH; Joo EJ; Son KH; Kim YS
Food Chem Toxicol; 2013 Sep; 59():703-8. PubMed ID: 23850994
[TBL] [Abstract][Full Text] [Related]
20. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
Spierings DC; de Vries EG; Vellenga E; de Jong S
Cell Death Differ; 2003 Jul; 10(7):808-22. PubMed ID: 12815464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
